Carpenter Technology (CRS)
NYSEIndustrialsSteelSnapshot 2026-10-29
$298.72+6.69%
Close 2026-10-29 · 1-day change
NYSEIndustrialsSteelSnapshot 2026-10-29
Research Workspace
Put CRS beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Industrial Machinery & Supplies & Components is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Revenue grows at least 15% year-over-year: Comparison needs review.
View ThesisMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on capital allocation, earnings delivery, the balance sheet, market reaction to earnings.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 2% on a typical day and fell roughly 55% in its worst 12-month stretch.
View RiskCRS rests on growing operating income and cash generation, despite fragile cash backing. Revenue growth slowed from 13% to 9% year over year. Q1 FY2027 earnings beat consensus, and the fiscal 2027 cash outlook remained unchanged. CRS trades at 24× P/E versus a 24× peer median. The price reflects less growth than our forecast. A 22% next-quarter miss probability and weak cash backing threaten the case. The thesis pillar of at least 15% revenue growth needs review; comparison is unverified. Peer multiples imply a price about 17% above where it trades. The thesis is on watch; this read is provisional.
Trailing returns as of 2026-10-29. CRS is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 9 analysts currently covering CRS (as of Oct 2026).
Based on 3 Wall Street analysts offering 12-month price targets for CRS in the last 4 months.
Continue this research
Compare CRS with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| CRS Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 11 valuation methods, at three horizons. As of 2026-10-29. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Industrial Machinery & Supplies & Components — fair value, gap to price, and forward P/E.
Compare the value case
Put CRS next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Increase operating income and cash generation
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-29. EPS is implied from price ÷ P/E. Not investment advice.
Current $298.72
The last 12 months of price, then the range of analyst 12-month targets from today’s $298.72.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Fiscal 2029 operating income target and maintained fiscal 2027 free cash flow outlook support earnings and cash-generation objectives.
Strong demand could enhance revenue growth.
Strength in aerospace materials supports growth.
Sustained cash flow growth supports revenue objectives.
New board member may enhance strategic direction.
Brownfield expansion project aids growth strategy.
Buyback confidence supports capital allocation strategy.
Leadership change poses uncertainty.
